News 27 Ott 2021 The University of Bern has developed a non-contagious SARS-CoV-2 model Researchers of the University of Bern and the Rockefeller University have developed a non-contagious SARS-CoV-2 model that makes it easier to cha...
Actualités 27 Ott 2021 L’Université de Berne met au point un modèle non contagieux du SARS-CoV-2 Des chercheurs de l'Université de Berne et de l'Université Rockefeller ont mis au point un modèle non contagieux du SARS-CoV-2 qui permet de cara...
Success stories 25 Mag 2023 CSL Behring: “The deciding factors were time to market and the proven track record of the Bern site.” CSL Behring For over a century, CSL Behring (CSLB) has kept its founding promise to help patients suffering from rare and serious diseases. It specializes in...
News 06 Dic 2021 Roche tests able to detect Omicron The Roche subsidiary TIB Molbiol has developed new coronavirus testing kits that can also detect the new Omicron variant of the disease. These te...
News 08 Mar 2021 A team from the University of Bern assesses the transmissibility of new SARS-CoV-2 virus mutants An international team involving researchers from the Institute of Virology and Immunology of the Federal Food Safety and Veterinary Office and th...
Aktuell 23 Mag 2023 Universität Basel und RocketVax stellen neuen COVID-Impfstoff vor Forschende der Universität Basel haben mit dem Biotech-Start-up RocketVax ein neues Konzept für einen Corona-Impfstoff entwickelt. Er beruht auf ...
News 09 Dic 2020 Vaud-based medtech company Abionic launches new tool for faster triage of Covid-19 patients With the launch of its CE-Mark certified device cSOFA, which assesses the severity of Covid-19 among patients within only five minutes of analyzi...
News 07 Set 2020 Roche testing for coronavirus and flu simultaneously The U.S. Food and Drug Administration has given the Basel-based life sciences company Roche authorization to use a test that simultaneously tests...
News 11 Ago 2020 Moderna driving forward production of vaccine from Basel The Swiss government has just signed a supply contract with Moderna for 4.5 million doses of a coronavirus vaccine. The US company is now opening...
News 07 Mag 2020 Bern synthetic coronavirus clone goes “viral” In mid-February, a team of researchers from the University of Bern succeeded in reconstructing a synthetic clone of the novel coronavirus using a...
News 27 Gen 2021 Institute develops double antibody against COVID-19 Researchers at the Institute for Research in Biomedicine have managed to combine two antibodies against COVID-19 into a single entity. This doubl...
News 07 Ott 2020 Lonza to start manufacturing Moderna’s Covid-19 vaccine this December Lonza's new building dedicated to the manufacturing of Moderna's Covid-19 vaccine will be operational starting December 2020. 300 million doses w...
News 21 Ago 2020 Researchers develop novel approach against the coronavirus The Swiss National Science Foundation is funding a novel approach for a coronavirus vaccine. This approach developed by virologist Cornel Fraefel...
Aktuell 08 Feb 2023 RocketVax erhält frisches Kapital Das Biotech-Start-up RocketVax hat eine weitere Finanzierungsrunde erfolgreich abgeschlossen. Die zusätzlichen Mittel fliessen vor allem in die W...
News 27 Mag 2020 Celonic agrees cooperation to combat coronavirus The Basel-based biopharmaceutical company Celonic Group has agreed a partnership with Airway Therapeutics from the USA. Together, the two compani...
News 17 Apr 2020 Roche launches new antibody test on the market The Basel-based pharmaceutical and diagnostics group Roche has developed a new test to verify the presence of antibodies against the coronav...